{
    "nctId": "NCT03167359",
    "briefTitle": "Hypofractionated Radiotherapy in Breast Cancer",
    "officialTitle": "A Pilot Study of Hypofractionated Simultaneous Integrated Boost Radiotherapy in Stage 0, I and III Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer, Breast, Inflammation",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 74,
    "primaryOutcomeMeasure": "Number of Participants Per Cutaneous Toxicity Grade (0, 1, 2, 3, 4)",
    "eligibilityCriteria": "Inclusion Criteria:\n\nParticipants must have one or more of the following characteristics and be eligible for breast or chest wall with or without regional nodal radiotherapy:\n\n* Prior Chemotherapy for Breast Cancer\n* Greater than 25 cm of breast separation (the largest distance on an axial slice of the planning CT simulation scan between the entry and exit points of the radiation beam on the body)\n* Non-Caucasian Race\n* Less than or equal to 50 years of age\n* Requiring regional nodal irradiation without evidence of N3 disease\n\nExclusion Criteria:\n\n* Males will be excluded\n* Women who are pregnant or nursing a child may not take part in this study",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT"
}